US Patent 7115559 Method for treating coumarin-induced hemorrhage
Patent 7115559 was granted and assigned to ZymoGenetics on October, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Paul D. Bishop0
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+242 characters)
Article
Patent abstract
Use of factor XIII for treating coumarin-induced hemorrhage or bleeding. The coumarin may be warfarin or dicoumarol. A patient having coumarin-induced bleeding is treated with factor XIII alone or in conjunction with vitamin K.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 17 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07115559 Method for treating coumarin-induced hemorrhage US Patent 7115559 Method for treating coumarin-induced hemorrhage
Infobox
Patent Number
071155590
Patent Number
71155590
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071155590
Date of Patent
October 3, 2006
0Patent Application Number
104890820
Date Filed
September 10, 2002
0Official Website
Patent Primary Examiner
Edits on 7 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 17 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07115559 Method for treating coumarin-induced hemorrhage
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07115559
Date of patent
October 3, 2006
Patent application number
10489082
Date Filed
September 10, 2002
Patent primary examiner
Find more entities like US Patent 7115559 Method for treating coumarin-induced hemorrhage
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.